Infection Surveillance Solution Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

Infection surveillance solutions provide real-time monitoring, reporting, and analytics capabilities to help healthcare facilities identify infection outbreaks, monitor antimicrobial resistance patterns, and comply with public health mandates. The global market, valued at roughly $0.878 billion in 2025, encompasses a range of products including standalone surveillance software, modules integrated into EHR systems, and data analytics services tailored for infection preventionists and epidemiologists.

• •Market valued at approximately $0.878 billion in 2025, with a projected 13.0% CAGR
• •Serves hospitals, long-term care facilities, ambulatory care centers, and public health agencies
• •Driven by the global burden of HAIs, which the WHO estimates affect millions of patients annually

Stricter regulatory frameworks are a primary catalyst, as governments worldwide impose mandatory HAI reporting and impose financial penalties on non-compliant facilities. The ongoing digitization of healthcare infrastructure, including widespread EHR adoption, provides the data foundation for more sophisticated and scalable surveillance platforms. Additionally, rising concerns over antibiotic-resistant organisms and post-COVID-19 infection control priorities have elevated infection surveillance from a back-office function to a strategic clinical imperative.

• •Mandatory HAI reporting regulations such as the U.S. CMS Hospital-Acquired Condition Reduction Program incentivize compliance
• •Expanding use of EHR systems enables real-time data extraction and automated surveillance workflows
• •Growing prevalence of multidrug-resistant organisms and post-pandemic preparedness concerns

The market is commonly segmented by product type, software platforms and professional services, and by deployment model, with cloud-based solutions gaining momentum over on-premise installations due to flexibility and lower infrastructure costs. Geographically, North America holds the largest share, led by comprehensive U.S. regulatory frameworks and advanced healthcare IT infrastructure, while Europe follows closely behind with strong national infection control mandates. Asia-Pacific represents the fastest-growing region, fueled by expanding healthcare budgets, growing hospital infrastructure, and rising HAI awareness in countries such as China, India, and Japan.

• •North America leads in market share due to stringent regulations and early EHR adoption
• •Europe follows with strong national surveillance programs and funding support
• •Asia-Pacific is the fastest-growing region, driven by healthcare modernization and rising infection control investments

What are the recent trends and outlook?

Artificial intelligence and machine learning are increasingly being embedded into surveillance platforms to predict outbreak patterns, reduce manual chart-review burdens, and accelerate antimicrobial stewardship workflows. The convergence of infection surveillance with broader real-world evidence and population health management platforms is expected to further expand market opportunities. As healthcare systems globally prioritize patient safety and value-based care, the infection surveillance solutions market is well-positioned to sustain its double-digit growth trajectory through the early 2030s.

• •AI and predictive analytics are being integrated to automate outbreak detection and reduce manual review workloads
• •Convergence with population health management and real-world evidence platforms is expanding addressable markets
• •Antimicrobial stewardship programs are driving new demand for linked surveillance and decision-support capabilities